Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
2.57
-0.03 (-1.15%)
At close: Sep 25, 2025, 10:15 AM
Chemomab Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CMMB stock have an median target of 26.5, with a low estimate of 25 and a high estimate of 28. The median target predicts an increase of 931.13% from the current stock price of 2.57.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 25 | 26.5 | 26.5 | 28 |
| Change | 872.76% | 931.13% | 931.13% | 989.49% |
Latest Analyst Insight Report
Oppenheimer has maintained an Outperform rating on... Unlock content with Pro Subscription
Updated Nov 15, 2024
| Rating | Nov 24 | Feb 25 | May 25 | Aug 25 |
|---|---|---|---|---|
| Strong Buy | 0 | 1 | 0 | 0 |
| Buy | 1 | 0 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 |
Financial Forecast this Year
Revenue This Year
n/a
Revenue Next Year
24.4M
from 0
Increased by n/a%
EPS This Year
-0.12
from -0.78
Increased by 84.6%
EPS Next Year
-0.2
from -0.12
Increased by -66.7%